𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Protein tyrosine phosphatase ε increases the risk of mammary hyperplasia and mammary tumors in transgenic mice

✍ Scribed by Elson, Ari

Book ID
110062474
Publisher
Nature Publishing Group
Year
1999
Tongue
English
Weight
385 KB
Volume
18
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epithelial mesenchymal transition is a c
Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice
✍ Luigi Strizzi; Caterina Bianco; Nicola Normanno; Masaharu Seno; Christian Wechse 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 738 KB

## Abstract Epithelial‐mesenchymal transition (EMT) facilitates migration and invasion of epithelial tumor cells. Cripto‐1 (CR‐1), a member of the epidermal growth factor‐CFC protein family increases migration of cells in vitro. Here the expression of molecular markers and signaling molecules chara

Energy restriction and the risk of spont
Energy restriction and the risk of spontaneous mammary tumors in mice: A meta-analysis
✍ Miranda J.M. Dirx; Maurice P.A. Zeegers; Pieter C. Dagnelie; Ton van den Bogaard 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 91 KB 👁 2 views

## Abstract Our meta‐analysis was aimed at providing a systematic review of the literature regarding the effect of energy restriction on spontaneous mammary tumors in mice and at providing a more precise pooled (summary) estimate of the risk of mammary tumors. A sensitivity analysis was conducted t

Inhibitory effect of the peptide epitalo
Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice
✍ Vladimir N. Anisimov; Vladimir KH. Khavinson; Mauro Provinciali; Irina N. Alimov 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 133 KB 👁 2 views

Female FVB/N HER-2/neu transgenic mice from the age of 2 months were subcutaneously injected with saline, the peptide Epitalon(R) (Ala-Glu-Asp-Gly) or with the peptide Vilon(R) (Lys-Glu) in a single dose of 1 microg/mouse for 5 consecutive days every month. Epitalon treatment reduced the cumulative